STOCK TITAN

Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Silk Road Medical (Nasdaq: SILK), dedicated to decreasing stroke risk, will participate in the BofA Securities 2022 Healthcare Conference. The presentation is scheduled for May 11, 2022, at 5:20 p.m. PT. Interested individuals can access the live and archived webcast through the company's investors' section. The company is recognized for its innovative TransCarotid Artery Revascularization (TCAR) procedure, which aims to treat carotid artery disease and enhance patient outcomes.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2022 Healthcare Conference.

Management is scheduled to present on Wednesday, May 11, 2022 at 5:20 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


FAQ

What date is Silk Road Medical presenting at the BofA Securities 2022 Healthcare Conference?

Silk Road Medical will present on May 11, 2022.

What is the time of Silk Road Medical's presentation at the conference?

The presentation is scheduled for 5:20 p.m. Pacific Time.

How can I access Silk Road Medical's presentation?

The presentation can be accessed live and archived via the company's investors' section on their website.

What is the focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke, particularly through their TCAR procedure.

What is TCAR in relation to Silk Road Medical?

TCAR, or TransCarotid Artery Revascularization, is a procedure developed by Silk Road Medical to treat carotid artery disease.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
38.94M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE